New research is examining whether long-term use of the diabetes drug metformin is linked to differences in cancer risk, ...

Diabetes remission is defined as achieving an HbA1c (average blood sugar) level of less than 6.5 percent for at least one ...

The rise of weight-loss drugs such as Ozempic and Wegovy has been nothing short of meteoric, with millions turning to the injections to shed pounds and improve their health. But beneath the dramatic ...

Groundbreaking comparative study reveals best treatment for diabetes - Findings point to a paradigm shift in diabetes care, scientists say ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Estimate your federal taxes with our 1040 tax calculator and earn ...

The City of Providence, along other municipalities and states, is taking big pharma to court over the price of insulin.

Exclusive: Joseph Hamilton Broussard took the meds as directed, but he had received the wrong ones, the 91-year-old’s ...

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

According to a November poll from the Kaiser Family Foundation, one in eight Americans reported taking a GLP-1 drug, which ...

As an adjunctive treatment, empagliflozin improves glycaemic control in patients with HNF1A-related maturity-onset diabetes ...